Meeting
2023 ASCO Genitourinary Cancers Symposium
CDK12 pathogenic mutations in African American and White patients with prostate cancer.
Authors
Elisa M. Ledet
Tulane University, New Orleans, LA
Elisa M. Ledet , Nicholas Mitsiades , Ellen B. Jaeger , Calvin Y. Chao , A. Oliver Sartor
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Cancer Disparities
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 38)
DOI
10.1200/JCO.2023.41.6_suppl.38
Abstract #
38
Poster Bd #
B1
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Androgen-deprivation therapy and risk of dementia in patients with prostate cancer: Clinical outcomes from real-world data.
First Author: Dina Elantably
Poster
2023 ASCO Annual Meeting
Genetic ancestry associations with somatic mutations in a real-world cohort of over 3,000 patients with prostate cancer.
First Author: Francisco M De La Vega
Poster
2022 ASCO Annual Meeting
Analysis of MET exon 14 skipping mutations in non–small cell lung cancer (NSCLC) by histology and specific mutation.
First Author: Jennifer Aline Marks
Poster
2022 ASCO Genitourinary Cancers Symposium
Blood-based tumor mutational burden from circulating tumor DNA and immune checkpoint inhibitors in advanced prostate cancer.
First Author: Grant Rauterkus